Get started
Author

F. Tudor Ilca

Observed names: F Ilca, F Tudor Ilca, Florin T. Ilca, Florin Tudor Ilca, Ilca, F. Tudor, Ilca, Florin Tudor, Tudor Ilca
ORCID: 0000-0002-6582-8007
Observed ORCID: 0000-0002-6582-8007
OpenAlex ID: A5077596306
The Host Protein Calprotectin Modulates the Helicobacter pylori cag Type IV Secretion System via Zinc Sequestration
2014 · Jennifer A. Gaddy, Jana N. Radin, et al. · PLoS Pathogens · 88
PDF
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry
2024 · Pedro Horna, Matthew J. Weybright, et al. · Blood Cancer Journal · 68
PDF
Distinct Polymorphisms in HLA Class I Molecules Govern Their Susceptibility to Peptide Editing by TAPBPR
2019 · F. Tudor Ilca, Linnea Z. Drexhage, et al. · Cell Reports · 55
PDF
TAPBPR mediates peptide dissociation from MHC class I using a leucine lever
2018 · F. Tudor Ilca, Andreas Neerincx, et al. · eLife · 53
The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study
2015 · Esam Tolba Abualrous, Sunil Kumar Saini, et al. · PLoS ONE · 47
PDF
Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules
2018 · F. Tudor Ilca, Andreas Neerincx, et al. · Proceedings of the National Academy of Sciences · 39
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants
2021 · Mathieu Ferrari, Leila Mekkaoui, et al. · Journal of Virology · 38
PDF
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency
2021 · Adam Leach, F. Tudor Ilca, et al. · Antiviral Research · 16
PDF
The glycosylation status of MHC class I molecules impacts their interactions with TAPBPR
2021 · F. Tudor Ilca, Louise H. Boyle · Molecular Immunology · 15
PDF
Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein–Protein Interaction
2024 · Ram Jha, Alexander Kinna, et al. · ACS Chemical Biology · 8
The Ins and Outs of TAPBPR
2020 · Tudor Ilca, Louise H Boyle · Current Opinion in Immunology · 8
PDF
Antibody-mediated delivery of TAPBPR enables the redirection of virus-specific T cell responses to tumour cells
2022 · Andreas Neerincx, Aure Aflalo, et al. · Research Square · 2
PDF
MY006: allergen-targeted antibodies for the treatment of peanut allergy
2024 · Chiara Arena, Dimitri Bieli, et al. · Journal of Allergy and Clinical Immunology · 1
MY010: anti-allergen antibodies for the treatment of Fagales pollen allergy
2024 · Chiara Arena, Dimitri Bieli, et al. · Journal of Allergy and Clinical Immunology
Enzymatic processing and MHC loading 2Peptide editing mediated by TAPBPR
2022 · F. Tudor Ilca, Andreas Neerincx, et al. · Molecular Immunology
Molecular basis of TAPBPR-mediated peptide editing on MHC class I molecules
2019 · Ilca, Florin Tudor · Apollo (University of Cambridge)
PDF
Author response: TAPBPR mediates peptide dissociation from MHC class I using a leucine lever
2018 · F Tudor Ilca, Andreas Neerincx, et al. · eLife
Works count: 30
Citation count: 439
H-index: 9
I10-index: 9
Year
Topic
Type